BRAVA- BRAVA QUAD , CONCERTO II , CONSULTA , MAXIMO II, PROTECTA, PROTECTA XT,VIVA QUAD, QUAD S AND IX CRT-D'S
FDA premarket approval P010031/S487 · decided 2015-02-23
Approval details
- PMA number
- P010031
- Supplement
- S487
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- BRAVA- BRAVA QUAD , CONCERTO II , CONSULTA , MAXIMO II, PROTECTA, PROTECTA XT,VIVA QUAD, QUAD S AND IX CRT-D'S
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2015-01-29
- Decision date
- 2015-02-23
- Days to decision
- 25 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- ADD AN ADDITIONAL SUPPLIER FOR TANTALUM SUBSTRATES FOR CAPACITORS USED IN THE DEVICES.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.